Paget's disease and fibrous dysplasia

Otolaryngologic Clinics of North America

Volumn 36, Issue 4, 2003, Pages 707-732

  Hullar, Timothy E ^a   Lustig, Lawrence R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; DACTINOMYCIN; ETIDRONIC ACID; MITHRAMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; RISEDRONIC ACID; TILUDRONIC ACID;

CALCIUM BLOOD LEVEL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FIBROUS DYSPLASIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET BONE DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; SKULL BASE; SURGICAL TECHNIQUE; TEMPORAL BONE;

EID: 0041802830     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(03)00028-8     Document Type: Review

References (92)

1. Paget J. On a form of chronic inflammation of bones (osteitis deformans). Medico-Chirurgical Transactions 1877;60:37-63.
2. Byock JL. Skull and bones in Egil's saga: a Viking, a grave, and Paget's disease. Viator 1993;24:23-50.
3. Byock JL. Egil's bones. Sci Am 1995;1:82-8.
4. Klein RM, Norman A. diagnostic procedures for Paget's disease. Endocrinol Metab Clin North Am 1995;24(2):437-50.
5. Nager GT. Paget's disease of the temporal bone. Ann Otol Rhinol Laryngol 1975;32(4 Pt 3 Suppl 22):1-32.
6. Rosenberg A. Bones, joints, and soft tissue tumors. In: Cotran RS, Kumar V, Collins T, et al, editors. Robbins pathologic basis of disease. 6th edition. Philadelphia: WB Saunders; 1999.
7. d'Archambeau O, Parizel PM, Koekelkoren E, et al. CT diagnosis and differential diagnosis of otodystrophic lesions of the temporal bone. Eur J Radiol 1990;11:22-30.
8. Wu RK, Trumble TE, Ruwe PA. Familial incidence of Paget's disease and secondary osteogenic sarcoma: a report of three cases from a single family. Clin Orthop 1991;265:306-9.
9. Sherman BE, Chole RA. In vivo effects of surgical sympathectomy on intramembranous bone resorption. Am J Otol 1996;17(2):343-6.
10. Mirra JM. Pathogenesis of Paget's disease based on viral etiology. Clin Orthop 1987; 217:162-7.
11. Mills BG, Singer FR. Nuclear inclusions in Paget's disease of bone. Science 1976; 194(4261):201-2.
12. Basle MF, Fournier JG, Rozenblatt S, et al. Measles virus mRNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 1986;67:907-13.
13. Ooi CG, Fraser WD. Paget disease of bone. Postgrad Med J 1996;73(856):69-74.
14. Niedermeyer HP, Arnold W, Neubert WJ, et al. Persistent measles virus infection as a possible cause of otosclerosis: state of the art. Ear Nose Throat J 2000;79(8):552-8.
15. Reddy SV, Kurihara N, Menaa C, et al. Paget's disease of bone: a disease of the osteoclast. Rev Endocr Metab Disord 2001;2(2):195-201.
16. Cody JD, Singer FR, Roodman GD, et al. Genetic linkage of Paget's disease of the bone to chromosome 8q. Am J Hum Genet 1997;61(5):1117-22.
17. Nellissery MJ, Padalecki SS, Brkanac Z, et al. Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget's disease of bone. Am J Hum Genet 1998;63(3):817-24.
18. Siris ES. Paget's disease of bone. J Bone Miner Res 1998;13(7):1061-5.
19. Davies DG. Paget's disase of the temporal bone. Acta Otolaryngol 1968;(Suppl 242)66-1-47.
20. Khetarpal U, Schuknecht HG. In search of pathologic correlates for hearing loss and vertigo in Paget's disease. A clinical and histopathologic study of 26 temporal bones. Ann Otol Rhinol Laryngol Suppl 1990;145:1-16.
21. Ramsay HAW, Linthicum Jr. FH. Cochlear histopathology in Paget's disease. Am J Otolaryngol 1993;14(1):60-1.
22. Proops D, Bayley D, Hawke M. Paget's disease and the temporal bone-a clinical and histopathological review of six temporal bones. J Otolaryngol 1985;14(1):20-9.
23. Crain MR, Dolan KD. Internal auditory canal enlargement in Paget's disease appearing as bilateral acoustic neuromas. Ann Otol Rhinol Laryngol 1990;99(10 Pt 1):833-4.
24. Monsell EM, Bone HG, Cody DD, et al. Hearing loss in Paget's disease of bone: evidence of auditory nerve integrity. Am J Otol 1995;16(1):27-33.
25. Wootton R, Reeve J, Spellacy E, et al. Skeletal blood flow in Paget's disease of bone and its response to calictonin therapy. Clin Sci Mol Med 1978;54(1):69-74.
26. Singer FR, Roodman GD. Paget's disease of bone: principles of bone biology. San Diego (CA): Academic Press; 1996.
27. Poncelet A. The neurologic complications of Paget's disease. J Bone Miner Res 1999; 14(Suppl 2):88-91.
28. Gherardi G, Lo Cascio V, Bonucci E. Fine structure of nuclei and cytoplasm of osteoclasts in Paget's disease of bone. Histopathology 1980;4(1):63-74.
29. Ginsberg LE, Elster AD, Moody DM. MRI of Paget disease with temporal bone involvement presenting with sensorineural hearing loss. J Comput Assist Tomogr 1992;16(2):314-6.
30. Ravel R. Clinical laboratory medicine. 6th edition. St. Louis: Mosby; 1995.
31. Patel S, Coupland CA, Stone MD, et al. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy. Bone 1995;16(2):193-7.
32. Lando M, Hoover LA, Finerman G. Stabilization of hearing loss in Paget's disease with calcitonin and etidronate. Arch Otolaryngol Head Neck Surg 1988;14(8):891-4.
33. Uppal HS, D'Souza AR, Proops DW. Osseo-integration in Paget's disease: the bone-anchored hearing aid in the rehabilitation of Pagetic deafness. J Laryngol Otol 2001;115(11):903-6.
34. Smith J, Botet J, Yeh S. Bone sarcomas in Paget's disease: a study of 85 patients. Radiology 1984;152(3):583-90.
35. O'Driscoll SW, Hastings DE. Extension of monostotic Paget disease from the femur to the tibia after arthrodesis of the knee: a case report. J Bone Joint Surg Am 1989;71(1):129-32.
36. von Recklinghausen F. Die Fibrose oder deformierende Ostitis, die Osteomalacie und die osteoplastische Carcinose in ihren gegenseitigen Beziehungen. In: Festschrift Rudolf Virchow 1891. Berlin: Georg Reimer 1891.
37. Wells C. Polyostotic fibrous dysplasia in a 7th century Anglo-Saxon. Br J Radiol 1963; 36:925-6.
38. Gregg JB, Reed A. Monostotic fibrous dysplasia in the temporal bone: a late prehistoric occurrence. Am J Phys Anthropol 1980;52(4):587-93.
39. Nager GT, Kennedy DW, Kopstein E. Fibrous dysplasia: a review of the disease and its manifestations in the temporal bone. Ann Otol Rhinol Laryngol Suppl 1982;92: 1-52.
40. Windolz F. Cranial manifestations of fibrous dysplasia of bone. AJR Am J Roentgenol 1947;58:51-63.
41. Nager GT, Holliday MJ. Fibrous dysplasia of the temporal bone. Arch Otolaryngol Head Neck Surg 1984;93(6 Part 1):630-3.
42. Weill A. Pubertas praecox und knochenbrüchigkeit. Klin Wochenschr 1922;1:2114-5.
43. Gaupp V. Pubertas praecox bei Osteodystrophia fibrosa. Monatsschr Kinderheilkd 1932;53:312-22.
44. McCune DJ. Osteitis fibrosa cystica: the case of a nine year old girl who also exhibits precocious puberty multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936;52:743-7.
45. McCune DJ, Bruch H. Osteodystrophia fibrosa: report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin, and hyperthyroidism, with a review of the literature. Am J Dis Child 1937;54:806-48.
46. Albright F, Butler AM, Hampton AO, et al. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 1937;216:727-46.
47. Lustig LR, Holliday MJ, McCarthy EF, et al. Fibrous dysplasia involving the skull base and temporal bone. Arch Otolaryngol Head Neck Surg 2001;127(10):1239-47.
48. van Trillberg W. Fibrous dysplasia. In: Vinken P, Bruyn G, editors. Handbook of clinical neurology, vol. 14. Amsterdam: North Holland Publishing Co; 1972.
49. Reed R. Fibrous dysplasia of bone. Arch Pathol 1963;75:480-95.
50. Shenker A, Weinstein LS, Moran A, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 1993;123(4):509-18.
51. Ringel MD, Schwindinger WF, Levine MA. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine (Baltimore) 1996;75(4):171-84.
52. s as the molecular basis for the McCune-Albright syndrome. Arch Med Res 1999; 30(6):522-31.
53. Tinschert S, Gerl H, Gewies A, et al. McCune-Albright syndrome: clinical and molecular evidence of mosaicism in an unusual giant patient. Am J Med Genet 1999;83(2): 100-8.
54. α mutations and imprinting defects in human disease. Ann N Y Acad Sci 2002;968:173-97.
55. Bianco P, Robey PG. Diseases of bone and the stromal cell lineage. J Bone Miner Res 1999;14:335-41.
56. Candeliere GA, Glorieux FH, Prud'homme J, et al. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995; 332:1546-51.
57. Kim IS, Kim ER, Nam HJ, et al. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res 1999;52(5):235-40.
58. Spiegel AM, Weinstein LS. Pseudohypoparathyroidism. In: Scriver CR, Beaudet AL, Valle D, et al, editors. The metabolic and molecular bases of inherited disease, vol. 8. New York: McGraw-Hill; 2001. p. 4205-21.
59. Spujt H, Dorfman H, Fechner R, et al. Tumors of bone and cartilage: atlas of tumor pathology. Washington (DC): Armed Forces Institute of Pathology; 1970.
60. Mazabraud A, Girard J. Un cas particulier de dysplasie fibreuse à localizations osseuses et tendineuses. Rev Rhum 1957;34:652-9.
61. Prayson MA, Leeson MC. Soft-tissue myxomas and fibrous dysplasia of bone: a case report and review of the literature. Clin Orthop 1993;291:222-8.
62. Henschen F. Fall von Ostitis fibrosa mit multiplen Tumoren in der ungebenden Muskulatur. Verh Deutsch Ges Pathol 1926;21:93-7.
63. Wojno KJ, McCarthy EF. Fibro-osseous lesions of the face and skull with aneurysmal bone cyst formation. Skeletal Radiol 1994;23(1):15-8.
64. Maher CO, Friedman JA, Meyer FB, et al. Surgical treatment of fibrous dysplasia of the skull in children. Pediatr Neurosurg 2002;37(2):87-92.
65. Megerian CA, Sofferman RA, McKenna MJ, et al. Fibrous dysplasia of the temporal bone: ten new cases demonstrating the spectrum of otologic sequelae. Am J Otol 1995;16(4): 408-19.
66. Feuillan PP, Foster CM, Pescovitz OH, et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med 1986;315(18):1115-9.
67. Cuttler L, Jackson JA, uz-Zafar MS, et al. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 1989;68(6):1148-54.
68. Mastorakos G, Mitsiades NS, Dougas AG, et al. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities 60 years after the first report. Thyroid 1997;7(3):433-9.
69. Kirk JMW, Brain CE, Carson DJ, et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 1999;134(6):789-92.
70. Collins MT, Chebli C, Jones J, et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001;16(5):806-13.
71. Bolger WE, Ross AT. McCune-Albright syndrome: a case report and review of the literature. Int J Pediatr Otorhinolaryngol 2002;65:69-74.
72. Silva ES, Lumbroso S, Medina M, et al. Demonstration of McCune-Albright mutations in the liver of children with high gamma-GT progressive cholestasis. J Hepatol 2000; 32(1):154-8.
73. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 1986;29(4):321-4.
74. Greco MA, Steiner GC. Ultrastructure of fibrous dysplasia of bone: a study of its fibrous, osseous, and cartilaginous components. Ultrastruct Pathol 1986;10(1):55-66.
75. Riminucci M, Fisher LW, Shenker A, et al. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997;151(6):1587-600.
76. Candeliere GA, Roughley PJ, Glorieux FH. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 1997;21:201-26.
77. Chee GH, Chen JM. Fibrous dysplasia of the temporal bone. Oto Neurotol 2002; 23(3):405-6.
78. Tehranzadeh J, Fung Y, Donohue M, et al. Computed tomography of Paget disease of the skull versus fibrous dysplasia. Skeletal Radiol 1998;27(12):664-72.
79. Casselman JW, De Jonge I, Neyt I, et al. MRI in craniofacial fibrous dysplasia. Neuroradiology 1993;35(3):234-7.
80. Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostitic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 2000;137(3):403-9.
81. Lala R, Matarazzo P, Bertelloni S, et al. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 2000;89(2):188-93.
82. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994;343(8903):953-4.
83. Schoenau E, Rauch F. Fibrous dysplasia. Horm Res 2002;57(Suppl 2):79-82.
84. Bocca G, de Vries J, Cruysberg JRM, et al. Optic neuropathy in McCune-Albright syndrome: an indication for aggressive treatment. Acta Paediatr 1998;87:599-600.
85. Yavuzer R, Khilnani R, Jackson IT, et al. A case of atypical McCune-Albright syndrome requiring optic nerve decompression. Ann Plast Surg 1999;43(4):430-5.
86. Morrissey DD, Talbot JM, Schleuning AJ. Fibrous dysplasia of the temporal bone: reversal of sensorineural hearing loss after decompression of the internal auditory canal. Laryngoscope 1997;107(10):1336-40.
87. Chen YR, Breidahl A, Chang CN. Optic nerve decompression in fibrous dysplasia: indications, efficacy, and safety. Plast Reconstr Surg 1997;99(1):22-30.
88. Blanco P, Schaeverbeke T, Baillet L, et al. Chondrosarcoma in a patient with McCune-Albright syndrome. Rev Rhum Engl Ed 1999;66:177-9.
89. Yabut SM. Malignant transformation of fibrous dysplasia: a case report and review of the literature. Clin Orthop 1988;228:281-9.
90. Ruggiere P, Sim FH, Bone JR, et al. Malignancies in fibrous dysplasia. Cancer 1994; 73(5):1411-24.
91. Harris WH, Dudley HR, Barry RJ. The natural history of fibrous dysplasia. J Bone Joint Surg Am 1962;44A:207-33.
92. Ozaki T, Sugihara M, Nakatsuka Y, et al. Polyostotic fibrous dysplasia. A long-term followup of 8 patients. Int Orthop 1996;20(4):227-32.